Abstract
Medical applications in operations research have flourished over the last few decades, and one of the most prolific topics has been how to optimally design cancer treatments. The preponderance of this research has considered radiotherapy design, but several new procedures are emerging as alternatives to standard treatments. This paper addresses the developing treatment modality called photodynamic therapy (PDT), which uses the light-harvesting properties of a photosensitizer. The premise is that cells expire due to a toxic reaction caused by exposing a photosensitizer to a specific wavelength of light. The purpose of treatment design is to decide how to best treat the patient, meaning that cancerous tissues are damaged but that surrounding organs are not. This paper has two objectives. First, we develop a model that allows us to explore the design process. In particular, we develop a standard pharmacokinetic model to estimate the absorption and elimination of the photosensitizer. The biological model provides the data to cast the design process as a time dependent linear program. Second, we use the linear program to answer the question of whether or not PDT is a viable treatment for deep tissue cancers with the only drug currently approved in the USA. Our results indicate that even under optimal conditions, the treatments based on the currently approved drug are not capable of targeting tumors without destroying surrounding tissues. However, a treatment’s success significantly increases with the drug’s affinity for cancerous tissues.
Similar content being viewed by others
References
Bartolozzi F et al (2000) Operational research techniques in medical treatment and diagnosis. A review. Eur J Oper Res 121(3):435–466
Bourne D, Triggs E, Eadie M (1986) Pharmacokinetics for the Non-Mathematical. MTP Press Limited, The Hague, Netherlands
Bressler N, Bressler S (2000) Photodynamic therapy with verteporfin(visudyne): Impact on ophthalmology and visual sciences. Invest Ophthalmol Vis Sci 41:624–628
Chwilkowska A, Saczko J, Modrzycka T, Marcinkowska A, Malarska A, Bielewicz J, Patalas D, Banas T (2003) Uptake of photofrin II, a photosensitizer used in photodynamic therapy, by tumor cells in vivo. Acta Biochim Polonica 50(2):509–513
Dougherty T, Kaufman J, Goldfarb A, Weishaupt K, Boyle D, Mittleman A (1978) Photoradiation therapy for the treatment of malignant tumors. Cancer Res 38:2628–2635
Hasan T, Ortel B, Moor A (2000) Mechanisms of photodynamic therapy. In: Patrice T, Haeder D, Jori G (eds) Reviews in photosciences: photodynamic therapy. Elsevier, Amsterdam, Netherlands
Hasan T, Ortel B, Moor A, Pogue B (2003) Photodynamic therapy of cancer. In: Pollock R, Weichselbaum R, Gansler T, Holland J, E. Frei III E, Bast R, Kufe D (eds) Cancer medicine, 5th edn. B.C. Decker, pp 489–502
Holder A (2004) Radiotherapy treatment design and linear programming. In: Brandeau M, Sainfort F, Pierskalla W (eds) Operations research and health care: a handbook of methods and applications, chap 29. Kluwer, Dordrecht
Holder A (2003) Designing radiotherapy plans with elastic constraints and interior point methods. Health Care Manage Sci 6(1):5–16
Hopper C (2000) Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 1:212–219
Jacques S (1992) Laser-tissue interactions: photochemical, photothermal, and photomechanical. Surg Clin North Am 72(3):531–558
Jori G (1990) Factors controlling the selectivity and efficiency of tumour damage in photodynamic therapy. Lasers Med Sci 5(115):115–120
McCaughan J (1999) Photodynamic therapy: a review. Drugs Aging 15(1):49–68
McMurry J (2000) Organic chemistry, 5th edn. Brooks/Cole, Belmont
Oikonen V (2002) Model equations for [15O]H2O pet perfusion (blood flow) studies. In: Technical Report report TPCMOD0004, Turka PET Centre Modeling, Turku University Central Hospital
Pandey R, Zheng G (2000) Porphyrins as photosensitizers in photodynamic therapy. In: Kadish KM, Smith KM, Guilard R (eds) The Porphyrin handbook, vol 6. Academic, New York
Rosen I, Lane R, Morrill S, Belli J (1991) Treatment plan optimization using linear programming. Med Phys 18(2):141–152
Shepard D, Ferris M, Olivera G, Mackie T (1999) Optimizing the delivery of radiation therapy to cancer patients. SIAM Rev 41(4):721–744
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors are grateful for the comments of the editor and the referee on the original submission.
Rights and permissions
About this article
Cite this article
Holder, A., LLagostera, D. Optimal treatments for photodynamic therapy. 4OR 6, 167–182 (2008). https://doi.org/10.1007/s10288-007-0046-4
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10288-007-0046-4